Clinical Trials Browser

INDUSTRY × Immunoglobulin Light-chain Amyloidosis × 30 days × Clear all

NCT05184088 2026-06-02

CArdiag

Phase 3 Completed

Immunoglobulin Light-chain Amyloidosis, Amyloid Neuropathies, Familial

NCT05839626 2026-05-27

A Study to Investigate Safety and Efficacy With SAR445514 in Participants With Relapsed/Refractory Multiple Myeloma (RRMM) and Relapsed/Refractory Light-chain Amyloidosis (RRLCA)

Phase 1 Terminated

Immunoglobulin Light-chain Amyloidosis, Multiple Myeloma

NCT06963216 2026-05-11

A Study Investigating Coagadex in the Treatment AFXD Associated With AL Amyloidosis

Phase 3 Recruiting

Immunoglobulin Light-chain Amyloidosis, Blood Coagulation Disorders, Factor X Deficiency, Hematologic Diseases, Hemorrhagic Disorders

NCT05951049 2026-05-06

A Study of AT-02 in Subjects With Systemic Amyloidosis.

Phase 2 Active not recruiting

Immunoglobulin Light-chain Amyloidosis